Compounding

IRA Reduces Pharma Research, Lilly's Cunning Compounding Litigation, Elevance Lawsuit Dismissed

ZorroRX Rundown (4/24/25)

GLP-1s Outpace Specialty, Novo’s Pharm To Table Play, and AI Prior Auth Run Amok

ZorroRX Rundown (3/26/25)

C-SNP Surges, Lilly Sales Rise 45%, UHC’s Phone Call W/ Surgeon Mid-Procedure

ZorroCard Round Up (11/4/24)

More Ways PBMs Favoring Their Own Pharmacies (shocker), How The IRA Will Drive Compounding Pharmacy Growth, And Amazon's Healthcare Ambitions,

ZorroCard Round Up (10/9/24)

FDA Sued Over Tirzepatide Shortage Decision, Poor MA Members Face Supplemental Benefit Gap, and Maven Clinic celebrates ten years with $200 million.